Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 84

1.

Neutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomy.

Morizawa Y, Miyake M, Shimada K, Hori S, Tatsumi Y, Nakai Y, Anai S, Tanaka N, Konishi N, Fujimoto K.

Urol Oncol. 2016 Mar 30. pii: S1078-1439(16)00045-4. doi: 10.1016/j.urolonc.2016.02.012. [Epub ahead of print]

PMID:
27038696
2.

Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomas.

Morizawa Y, Miyake M, Shimada K, Hori S, Tatsumi Y, Nakai Y, Anai S, Tanaka N, Konishi N, Fujimoto K.

World J Surg Oncol. 2016 Feb 24;14(1):43. doi: 10.1186/s12957-016-0810-z.

3.

The best objective response of target lesions and the incidence of treatment-related hypertension are associated with the survival of patients with metastatic renal cell carcinoma treated with sunitinib: a Japanese retrospective study.

Miyake M, Kuwada M, Hori S, Morizawa Y, Tatsumi Y, Anai S, Hosokawa Y, Hayashi Y, Tomioka A, Otani T, Otsuka K, Nakagawa Y, Nakai Y, Samma S, Tanaka N, Fujimoto K.

BMC Res Notes. 2016 Feb 9;9(1):79. doi: 10.1186/s13104-016-1895-8.

4.

The optimal number of initial prostate biopsy cores in daily practice: a prospective study using the Nara Urological Research and Treatment Group nomogram.

Tanaka N, Shimada K, Nakagawa Y, Hirao S, Watanabe S, Miyake M, Anai S, Hirayama A, Konishi N, Fujimoto K.

BMC Res Notes. 2015 Nov 18;8:689. doi: 10.1186/s13104-015-1668-9.

5.

Ubiquilin2 as a novel marker for detection of urothelial carcinoma cells in urine.

Shimada K, Fujii T, Tatsumi Y, Anai S, Fujimoto K, Konishi N.

Diagn Cytopathol. 2016 Jan;44(1):3-9. doi: 10.1002/dc.23332. Epub 2015 Aug 25.

PMID:
26303000
6.

Expression of ferrochelatase has a strong correlation in protoporphyrin IX accumulation with photodynamic detection of bladder cancer.

Nakai Y, Tatsumi Y, Miyake M, Anai S, Kuwada M, Onishi S, Chihara Y, Tanaka N, Hirao Y, Fujimoto K.

Photodiagnosis Photodyn Ther. 2016 Mar;13:225-32. doi: 10.1016/j.pdpdt.2015.07.174. Epub 2015 Jul 28.

PMID:
26226642
7.

Review by urological pathologists improves the accuracy of Gleason grading by general pathologists.

Nakai Y, Tanaka N, Shimada K, Konishi N, Miyake M, Anai S, Fujimoto K.

BMC Urol. 2015 Jul 23;15:70. doi: 10.1186/s12894-015-0066-x.

8.

Clinical significance and therapeutic potential of prostate cancer antigen-1/ALKBH3 in human renal cell carcinoma.

Hotta K, Sho M, Fujimoto K, Shimada K, Yamato I, Anai S, Harada H, Tsujikawa K, Konishi N, Shinohara N, Nakajima Y.

Oncol Rep. 2015 Aug;34(2):648-54. doi: 10.3892/or.2015.4017. Epub 2015 May 29.

PMID:
26035443
9.

A Randomized Control Trial Comparing the Efficacy of Antiandrogen Monotherapy: Flutamide vs. Bicalutamide.

Nakai Y, Tanaka N, Anai S, Miyake M, Tatsumi Y, Fujimoto K.

Horm Cancer. 2015 Aug;6(4):161-7. doi: 10.1007/s12672-015-0226-1. Epub 2015 May 30.

PMID:
26024831
10.

Changes in lower urinary tract symptoms and quality of life after salvage radiotherapy for biochemical recurrence of prostate cancer.

Miyake M, Tanaka N, Asakawa I, Tatsumi Y, Nakai Y, Anai S, Torimoto K, Aoki K, Yoneda T, Hasegawa M, Konishi N, Fujimoto K.

Radiother Oncol. 2015 Jun;115(3):321-6. doi: 10.1016/j.radonc.2015.04.026. Epub 2015 May 16.

PMID:
25991382
11.

Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy.

Tomioka A, Tanaka N, Yoshikawa M, Miyake M, Anai S, Chihara Y, Okajima E, Hirayama A, Hirao Y, Fujimoto K.

BMC Cancer. 2015 May 20;15:420. doi: 10.1186/s12885-015-1429-0.

12.

Exploration of risk factors predicting outcomes for primary T1 high-grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: Long-term follow-up experience at a single institute.

Miyake M, Gotoh D, Shimada K, Tatsumi Y, Nakai Y, Anai S, Torimoto K, Aoki K, Tanaka N, Konishi N, Fujimoto K.

Int J Urol. 2015 Jun;22(6):541-7. doi: 10.1111/iju.12749. Epub 2015 Apr 8.

PMID:
25857336
13.

Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A randomized, double-blind, multicentre phase II/III study.

Inoue K, Anai S, Fujimoto K, Hirao Y, Furuse H, Kai F, Ozono S, Hara T, Matsuyama H, Oyama M, Ueno M, Fukuhara H, Narukawa M, Shuin T.

Photodiagnosis Photodyn Ther. 2015 Jun;12(2):193-200. doi: 10.1016/j.pdpdt.2015.03.008. Epub 2015 Apr 2.

PMID:
25843912
14.

Protoporphyrin IX induced by 5-aminolevulinic acid in bladder cancer cells in voided urine can be extracorporeally quantified using a spectrophotometer.

Nakai Y, Anai S, Onishi S, Masaomi K, Tatsumi Y, Miyake M, Chihara Y, Tanaka N, Hirao Y, Fujimoto K.

Photodiagnosis Photodyn Ther. 2015 Jun;12(2):282-8. doi: 10.1016/j.pdpdt.2014.12.010. Epub 2015 Jan 13.

PMID:
25595357
15.

Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil.

Tanaka N, Torimoto K, Asakawa I, Miyake M, Anai S, Hirayama A, Hasegawa M, Konishi N, Fujimoto K.

Radiat Oncol. 2014 Dec 29;9:302. doi: 10.1186/s13014-014-0302-7.

16.

Differences in adverse event profiles between everolimus and temsirolimus and the risk factors for non-infectious pneumonitis in advanced renal cell carcinoma.

Nozawa M, Ohzeki T, Tamada S, Hongo F, Anai S, Fujimoto K, Miki T, Nakatani T, Fukasawa S, Uemura H.

Int J Clin Oncol. 2015 Aug;20(4):790-5. doi: 10.1007/s10147-014-0764-5. Epub 2014 Oct 25.

PMID:
25342378
17.

Proposed salvage treatment strategy for biochemical failure after radical prostatectomy in patients with prostate cancer: a retrospective study.

Miyake M, Tanaka N, Asakawa I, Morizawa Y, Anai S, Torimoto K, Aoki K, Yoneda T, Hasegawa M, Konishi N, Fujimoto K.

Radiat Oncol. 2014 Oct 20;9:208. doi: 10.1186/1748-717X-9-208.

18.

A patient with medulloblastoma in its early developmental stage.

Shinojima N, Nakamura H, Tasaki M, Kameno K, Anai S, Iyama K, Ando Y, Seto H, Kuratsu J.

J Neurosurg Pediatr. 2014 Dec;14(6):615-20. doi: 10.3171/2014.8.PEDS13590. Epub 2014 Oct 10.

PMID:
25303160
19.

Photodynamic diagnosis of shed prostate cancer cells in voided urine treated with 5-aminolevulinic acid.

Nakai Y, Anai S, Kuwada M, Miyake M, Chihara Y, Tanaka N, Hirayama A, Yoshida K, Hirao Y, Fujimoto K.

BMC Urol. 2014 Aug 3;14:59. doi: 10.1186/1471-2490-14-59.

20.

[The control of respiratory organ motion in the field of radiology: the viewpoint of a radiation oncologist].

Nakamura K, Yoshitake T, Terashima K, Sasaki T, Ohga S, Asai K, Matsumoto K, Hirata H, Shinoto M, Yoshidome S, Anai S, Shioyama Y, Honda H.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2014 May;70(5):477-82. Japanese. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk